RATIONALE AND OBJECTIVE: Twin studies suggest that substance use initiation in children and adolescents is determined primarily by environmental influences, whereas the establishment of use patterns is strongly controlled by genetic factors. The present study analysed the effects of the serotonin transporter promoter polymorphism [5-HT transporter gene-linked polymorphic region (5-HTTLPR)] and the α(2A)-adrenoceptor C-1291G genotype (ADRA2A C-1291G) as well as their interaction effects on alcohol, tobacco and drug use from preadolescence to the late adolescence. METHODS: Initial sample of 9-year-old children of Estonian Children Personality Behaviour and Health Study (n = 583) was recalled at ages 15 and 18. Participants reported in all waves how frequently they smoked and used alcohol and illicit drugs. RESULTS: 5-HTTLPR had age-dependent effects on alcohol, tobacco and drug use: substance use did not differ by genotype at age 9, but at age 15, the participants with the short (s)/s genotype had higher tobacco use, and at age 18, they were more active alcohol, drug and tobacco users. Effects of ADRA2A C-1291G on drug use were dependent on gender, age and 5-HTTLPR. Males (age 18) with ADRA2A CG genotype, when compared to other participants, tended to have higher drug use especially when they had s/s genotype of 5-HTTLPR. CONCLUSIONS: Our results reveal that expression of genetic vulnerability for substance use in children and adolescents may depend on age, gender, interaction of genes, and type of substance.
RATIONALE AND OBJECTIVE: Twin studies suggest that substance use initiation in children and adolescents is determined primarily by environmental influences, whereas the establishment of use patterns is strongly controlled by genetic factors. The present study analysed the effects of the serotonin transporter promoter polymorphism [5-HT transporter gene-linked polymorphic region (5-HTTLPR)] and the α(2A)-adrenoceptor C-1291G genotype (ADRA2AC-1291G) as well as their interaction effects on alcohol, tobacco and drug use from preadolescence to the late adolescence. METHODS: Initial sample of 9-year-old children of Estonian Children Personality Behaviour and Health Study (n = 583) was recalled at ages 15 and 18. Participants reported in all waves how frequently they smoked and used alcohol and illicit drugs. RESULTS: 5-HTTLPR had age-dependent effects on alcohol, tobacco and drug use: substance use did not differ by genotype at age 9, but at age 15, the participants with the short (s)/s genotype had higher tobacco use, and at age 18, they were more active alcohol, drug and tobacco users. Effects of ADRA2AC-1291G on drug use were dependent on gender, age and 5-HTTLPR. Males (age 18) with ADRA2A CG genotype, when compared to other participants, tended to have higher drug use especially when they had s/s genotype of 5-HTTLPR. CONCLUSIONS: Our results reveal that expression of genetic vulnerability for substance use in children and adolescents may depend on age, gender, interaction of genes, and type of substance.
Authors: Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd Journal: Neuroimage Date: 2007-04-06 Impact factor: 6.556
Authors: Marcelo Schmitz; Daniel Denardin; Tatiana Laufer Silva; Thiago Pianca; Tatiana Roman; Mara Helena Hutz; Stephen V Faraone; Luis Augusto Rohde Journal: Biol Psychiatry Date: 2006-06-27 Impact factor: 13.382
Authors: Aryeh I Herman; Kristi M Kaiss; Rui Ma; John W Philbeck; Asfar Hasan; Humza Dasti; Paolo B DePetrillo Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-02-05 Impact factor: 3.568
Authors: Gene H Brody; Steven R H Beach; Robert A Philibert; Yi-Fu Chen; Man-Kit Lei; Velma McBride Murry; Anita C Brown Journal: J Consult Clin Psychol Date: 2009-02
Authors: Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger Journal: Science Date: 2002-07-19 Impact factor: 47.728
Authors: Lars Oreland; Gianvito Lagravinese; Simone Toffoletto; Kent W Nilsson; Jaanus Harro; C Robert Cloninger; Erika Comasco Journal: J Neural Transm (Vienna) Date: 2017-01-04 Impact factor: 3.575
Authors: Daniel E Adkins; Shaunna L Clark; William E Copeland; Martin Kennedy; Kevin Conway; Adrian Angold; Hermine Maes; Youfang Liu; Gaurav Kumar; Alaattin Erkanli; Ashwin A Patkar; Judy Silberg; Tyson H Brown; David M Fergusson; L John Horwood; Lindon Eaves; Edwin J C G van den Oord; Patrick F Sullivan; E J Costello Journal: Twin Res Hum Genet Date: 2015-06-17 Impact factor: 1.587
Authors: Kenneth Blum; David Baron; Lisa Lott; Jessica V Ponce; David Siwicki; Brent Boyett; Bruce Steinberg; Edward J Modestino; Lyle Fried; Mary Hauser; Thomas Simpatico; Bill W Downs; Thomas McLaughlin; Raju Hajela; Rajendra D Badgaiyan Journal: Curr Psychopharmacol Date: 2020